RI
MDCO

RTW Investments’s Medicines Co MDCO Stock Holding History

RTW Investments’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-572,689
Closed -$28M – 34
2017
Q1 		$28M Buy
572,689
+198,426
+53% +$9.05M 7.37% 6
2016
Q4 		$12.7M Buy
374,263
+251,263
+204% +$8.91M 4.78% 7
2016
Q3 		$4.64M Buy
+123,000
New +$4.64M 1.4% 19

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RTW Investments's MDCO Position: Q2 2017 in Review

RTW Investments sold out of Medicines Co (MDCO) in Q2 2017, closing a stake of 572,689 shares — an estimated $28M sold.

RTW Investments first reported a position in MDCO in Q3 2016 and held it in 3 quarters. The position peaked at $28M in Q1 2017. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

  • RTW Investments reported no remaining Medicines Co position as of Q2 2017 after selling out during the quarter.
  • RTW Investments sold 572,689 Medicines Co shares in Q2 2017, an estimated $28M.
  • RTW Investments first reported a position in Medicines Co in Q3 2016 and held it in 3 quarters.
  • RTW Investments's Medicines Co position peaked at $28M in Q1 2017.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on RTW Investments's 13F filing for Q2 2017, filed 14 Aug 2017.